Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
ACRS · NASDAQ · Pharmaceutical Preparations
$3.44−0.06 (−1.71%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Aclaris Therapeutics (ACRS) · oqro.io/stocks/ACRS · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
5%+ stake · Stake as of Sep 30, 2026 · Filed Nov 16, 2026
Biosion, Inc. cut its ACRS stake below 5% (4.7%)SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Ra Capital Management, L.P. disclosed an increased position in ACRS for Q2 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Deep Track Capital, LP disclosed a new position in ACRS for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Frazier Life Sciences Management, L.P. disclosed a new position in ACRS for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Ra Capital Management, L.P. disclosed a new position in ACRS for Q1 2026SourceInsider trade · Traded Nov 19, 2024 · Filed Nov 20, 2024
Director purchased ~$1.5M of ACRS shares in the open marketSource